Boston Scientific (BSX) PT Raised to $26 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Boston Scientific (BSX) PT Raised to $23.50 at Evercore ISI
April 27, 2016 1:02 PM EDTEvercore ISI analyst Vijay Kumar raised estimates and his price target on Boston Scientific (NYSE: BSX) to $23.50 (from $21.50) due to market multiple expansion. The firm maintained a Buy rating.
FY16 EPS was raised from $1.06 to $1.11 mainly due to higher organic revenue growth (mainly from... More
Boston Scientific (BSX) Gains Following Strong Results, Outlook
April 27, 2016 9:53 AM EDTBoston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last traded up 8.9%.
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the... More
Boston Scientific (BSX) Tops Q1 EPS by 4c; Boosts FY16 Outlook
April 27, 2016 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.91 billion.
GUIDANCE:
Boston Scientific sees Q2 2016 EPS of $0.25-$0.27, versus the consensus of $0.26.... More
